Scott_Weaver

Scott Weaver PhD

Galveston National Laboratory

John Sealy Distinguished University Chair in Human Infections & Immunity

Director, Institute for Human Infections and Immunity

Professor and Chair, Department of Microbiology and Immunology

Scientific Director, Galveston National Laboratory

Professor Weaver is a virologist and vector biologist who studies arthropod-borne viruses (arboviruses), their transmission by mosquitoes, and develops vaccines to control the diseases that they cause. His research encompasses the ecology and epidemiology of enzootic arbovirus transmission cycles, virus-mosquito interactions, pathogenesis, and emergence mechanisms of epidemic strains. Recently he has focused on chikungunya and Zika viruses, which in 2013 arrived in the Americas to cause major epidemics. His chikungunya vaccine, licensed to Takeda Pharmaceuticals, is in late preclinical development. Prof. Weaver has published 300 peer-reviewed research papers, and has received the Walter Reed Medal from the Am. Soc. Trop. Med. Hyg. (ASTMH) for distinguished accomplishment in tropical medicine, and the Robert C. Gallo Award for Scientific Excellence from the Global Virus Network (GVN). He is a Fellow of the ASTMH, the American Academy of Microbiology and the National Academy of Inventors. Prof. Weaver chairs/co-chairs GVN’s Chikungunya and Zika Task Forces, and serves as PI for the CDC-funded Western Gulf Center of Excellence for Vector-borne Diseases.


Appearances